Skip to content

Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations

Effects of Dexmedetomidine on Oxygenation and Lung Mechanics in Morbidly Obese Patients Undergoing Bariatric Operations: A Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02843698
Enrollment
42
Registered
2016-07-26
Start date
2016-09-30
Completion date
2017-08-26
Last updated
2017-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restrictive Lung Disease

Brief summary

The study aims to investigate the effect of dexmedetomidine on oxygenation and lung mechanics in morbidly obese patients

Detailed description

The patients of interest are morbid obese patients scheduled for bariatric surgery. Dexmeditomidine will be infused intraoperatively after induction of anesthesia. lung mechanics (dead space and compliance) as well as oxygenation (PF ratio) will be monitored intraoperatively and postoperatively

Interventions

DRUGDexmedetomidine

Dexmedetomidine infusion was previously reported to improve oxygenation and lung dynamics in patients with obstructive lung diseases. In our study we are going to investigate its effect on oxygenation and lung dynamics in restrictive lung disease

DRUGNormal saline

Normal saline

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

\- Morbid obese (body mass index \> 40) with documented restrictive lung disease scheduled to bariatric operation.

Exclusion criteria

* Heart failure * ِِِِArrhythmia * Heart block * Severe liver or kidney impairment.

Design outcomes

Primary

MeasureTime frameDescription
Oxygenation2 hoursassessed by P/F ratio

Secondary

MeasureTime frameDescription
Lung mechanics2 hourslung compliance and dead space
arterial blood pressure2 hoursarterial blood pressure measured in mmHg
plateau airway pressure2 hoursplateau airway pressure measured in cmH2o
heart rate2 hoursnumber of heart beats per minute

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026